Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05501327 · ClinicalTrials.gov registry record · Phase 2
Dose Regimen Study of SLI-F06 in Healthy Volunteers
A Phase 2 study of Scar and Wound Healing, sponsored by Scarless Laboratories.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
- 2
- Study locations
NCT05501327 is a Phase 2 study of Scar and Wound Healing that is actively recruiting participants, run by Scarless Laboratories. The registered enrollment target is 30 participants, below the 47-participant average among 15 other Scar trials with a reported enrollment target (36% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT05501327, a Phase 2 study of Scar and Wound Healing, is actively recruiting participants, sponsored by Scarless Laboratories.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
- 2
- Study locations
Study Summary
Multi-center, dose-regimen, double-blind study evaluating the safety and efficacy of 4 doses of SLI-F06 compared with vehicle for improvement in scar appearance
Conditions Studied
Interventions
- DRUG SLI-F06
Study Locations (2)
California
- California Dermatology & Clinical Research Institute - Encinitas
Texas
- DermResearch - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-07-25 |
| Est. Completion | 2024-10-25 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05501327
The ClinicalTrials.gov registry entry for NCT05501327 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 47-participant average among 15 other Scar trials with a reported enrollment target (36% lower). The listed sponsor is Scarless Laboratories, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Scar appearing as the primary indexed condition, and to 1 intervention - of which SLI-F06 is the first listed.
NCT05501327 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Texas.
Frequently Asked Questions
What is clinical trial NCT05501327 about?
NCT05501327 is a clinical study titled "Dose Regimen Study of SLI-F06 in Healthy Volunteers". Multi-center, dose-regimen, double-blind study evaluating the safety and efficacy of 4 doses of SLI-F06 compared with vehicle for improvement in scar appearance
What is the current status of trial NCT05501327?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2022-07-25. Estimated completion is 2024-10-25.
What conditions does trial NCT05501327 study?
This clinical trial studies the following conditions: Scar, Wound Healing.
What interventions are being tested in trial NCT05501327?
The interventions under investigation include: SLI-F06 (DRUG).
Who is sponsoring clinical trial NCT05501327?
This trial is sponsored by Scarless Laboratories, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05501327 being conducted?
This trial has 2 study locations across California, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Scar
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Randomized Controlled Trial Examining the Efficacy of Botulinum Toxin in Biopsy Scar Minimization
ACTIVE NOT RECRUITING · Phase 2
-
A Study of Granexin® Gel for the Reduction of Scar Formation in Surgical Wounds Following Bilateral Anchor Incision Breast Surgery
COMPLETED · Phase 2
-
Microneedling vs Dermabrasion for Early Facial Scar Resurfacing
RECRUITING · NA
-
Zinc Oxide Versus Petrolatum Following Skin Surgery
RECRUITING · Early Phase 1
-
Paraffin Wax and Exercise Prospective
RECRUITING · NA
-
Impact of Suture Type on Pigment Disturbances in Patients of Skin of Color
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.